SEHK:3690
SEHK:3690Hospitality

Meituan (SEHK:3690): Exploring Valuation After Recent Share Price Volatility

Meituan (SEHK:3690) has recently seen its stock fluctuate, drawing attention from investors who are watching the company’s performance over the past month. There is growing curiosity about what is driving sentiment around the stock now. See our latest analysis for Meituan. Zooming out, Meituan’s share price has struggled to regain its footing this year. Momentum has faded since January and a 1-year total shareholder return of -41.04% highlights the challenging climate for the stock. Recent...
SEHK:2142
SEHK:2142Biotechs

A Look at HBM Holdings (SEHK:2142) Valuation Following AI-Focused Partnership With Evinova China

HBM Holdings (SEHK:2142) has announced a strategic partnership with Evinova China to leverage artificial intelligence and digital technologies in biologics research and development. This move is expected to add momentum to its innovation pipeline and market positioning. See our latest analysis for HBM Holdings. HBM Holdings’ latest surge, up 4% in a single day and 11.6% over the last week, follows the announcement of its AI-driven partnership with Evinova China. This signals that investors...
SEHK:2598
SEHK:2598Diversified Financial

Exploring Lianlian DigiTech (SEHK:2598) Valuation: Is the Market Overlooking Opportunity?

Lianlian DigiTech (SEHK:2598) has been catching some attention lately, with shares moving in various directions over the past week and month. Investors are weighing recent trading patterns in relation to the company’s overall financial trajectory. See our latest analysis for Lianlian DigiTech. Lianlian DigiTech’s share price has swung lower over the past quarter, with a 90-day share price return of -17.96% and a one-year total shareholder return of -13.4%. While momentum has faded recently,...
SEHK:1548
SEHK:1548Life Sciences

Why Genscript Biotech (SEHK:1548) Is Up 8.0% After Legend Biotech’s CARVYKTI Drives Smaller Q3 Loss

Earlier this week, Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported a significant reduction in net losses for the third quarter of 2025, alongside strong sales growth for its CARVYKTI product. This disclosure, released around Genscript’s Analyst/Investor Day, places enhanced focus on the financial ties between the two companies and the implications for Genscript’s broader business outlook. We’ll now explore how Legend Biotech’s improved...
SEHK:1651
SEHK:1651Machinery

Strong First-Half Earnings Could Be a Game Changer For Precision Tsugami (China) (SEHK:1651)

Precision Tsugami (China) Corporation Limited recently announced its half-year earnings, reporting sales of CNY 2,496.9 million and net income of CNY 502.25 million for the period ended September 30, 2025, both of which were higher than the prior year. The company's substantial increases in both revenue and earnings per share highlight ongoing momentum in its operational performance and profitability. We'll explore how this robust earnings growth shapes Precision Tsugami (China)'s investment...
SEHK:2356
SEHK:2356Banks

Dah Sing Banking Group (SEHK:2356): Assessing Valuation Following Investor Confidence Index Launch and 24/7 US Trading Upgrade

Dah Sing Banking Group (SEHK:2356) has rolled out its first Investor Confidence Index, aiming to measure how Hong Kong investors feel about the market. In addition, the bank is upgrading its US securities trading to offer 24/7 access and is considering virtual asset ETF services. See our latest analysis for Dah Sing Banking Group. Dah Sing Banking Group’s latest innovations come as its share price momentum has steadily accelerated, climbing 22.7% over the past quarter and showing a robust...
SEHK:551
SEHK:551Luxury

Yue Yuen (SEHK:551): Assessing Valuation After Latest Earnings Show Decline in Sales and Profit

Yue Yuen Industrial (Holdings) (SEHK:551) just released its earnings for the nine months ended September 30, 2025, showing both sales and net income have slipped compared to the prior year’s period. See our latest analysis for Yue Yuen Industrial (Holdings). While Yue Yuen’s latest earnings showed weaker sales and profit, investors seem encouraged. The share price is up 17.7% over the last month alone. Momentum is picking up, and the total shareholder return for the past year now stands at...